Alpha 2.0
Login Register
» Authors » Deepika Nayak

Deepika Nayak

Explore the profile of Deepika Nayak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 234
Followers 0
Related Specialties
Biochemistry
Cell Biology
Pharmacology
Top 10 Co-Authors
Chanakya Nath Kundu
Anmada Nayak
Sumit Siddharth
Sarita Das
Chinmayee Sethy
Rajalaxmi Pradhan
Satya Narayan
Sefinew Molla
Subhajit Chatterjee
Michael D Wyatt
Published In
Int J Biochem Cell Biol
Cell Oncol (Dordr)
Sci Rep
Mol Pharm
Indian J Nucl Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Retraction Note: TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions
Das S, Nayak A, Siddharth S, Nayak D, Narayan S, Kundu C
Cell Oncol (Dordr) . 2025 Feb; PMID: 39962014
No abstract available.
2.
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A
Nayak D, Paul S, Das C, Bhal S, Kundu C
J Cell Commun Signal . 2022 Nov; 17(3):609-626. PMID: 36326988
Cancer stem cells (CSCs) cause drug resistance in cancer due to its extensive drug efflux, DNA repair and self-renewal capability. ATP binding cassette subfamily G member 2 (ABCG2) efflux pump...
3.
Diastereoselective synthesis of novel spiro indanone fused pyrano[3,2-]chromene derivatives following hetero-Diels-Alder reaction and anticancer studies
Panda P, Nayak S, Sahoo S, Mohapatra S, Nayak D, Pradhan R, et al.
RSC Adv . 2022 May; 8(30):16802-16814. PMID: 35540554
The development of concise methods for the synthesis of small functionalised spirocyclic molecules is important in the search of new bioactive molecules. To contribute this, here we represent a diastereoselective...
4.
Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC)
Pawara R, Ahmad I, Nayak D, Wagh S, Wadkar A, Ansari A, et al.
Bioorg Chem . 2021 Aug; 115:105234. PMID: 34399322
T790M mutation is the most common mechanism of acquired resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). To overcome this resistance, 4-anilinoquinazoline-based irreversible inhibitors afatinib, dacomitinib has...
5.
Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effects
Sisodiya S, Paul S, Chaudhary H, Grewal P, Kumar G, Daniel D, et al.
Bioorg Med Chem Lett . 2021 Jul; 49:128274. PMID: 34303812
Two series of (hetero)arylamino-naphthoquinones and benzo-fused carbazolequinones were considered for study with the rationale that related structural motifs are present in numerous drugs, clinical trial agents, natural products and hTopoIIα...
6.
Corrigendum to "The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4" [Int J Biochem Cell Biol, 2018, Sep, 102, 151-160]
Siddharth S, Nayak A, Das S, Nayak D, Panda J, Wyatt M, et al.
Int J Biochem Cell Biol . 2020 Oct; 130:105860. PMID: 33097423
No abstract available.
7.
Correction to "Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer"
Hembram K, Chatterjee S, Sethy C, Nayak D, Pradhan R, Molla S, et al.
Mol Pharm . 2020 Jul; 17(8):3150. PMID: 32672463
No abstract available.
8.
Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway
Nayak D, Tripathi N, Kathuria D, Siddharth S, Nayak A, Bharatam P, et al.
Int J Biochem Cell Biol . 2019 Dec; 119:105682. PMID: 31877386
Cancer stem cell like cells (CSCs) present a challenge in the management of cancers due to their involvement in the development of resistance against various chemotherapeutic agents. Over expression of...
9.
PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade
Molla S, Hembram K, Chatterjee S, Nayak D, Sethy C, Pradhan R, et al.
Pathol Oncol Res . 2019 Nov; 26(4):2091-2103. PMID: 31768967
Although Olaparib (Ola, a PARP-inhibitor), in combination with other chemotherapeutic agents, was clinically approved to treat prostate cancer, but cytotoxicity, off-target effects of DNA damaging agents limit its applications in...
10.
Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse
Sethy C, Goutam K, Nayak D, Pradhan R, Molla S, Chatterjee S, et al.
J Cancer Res Clin Oncol . 2019 Oct; 146(1):245-259. PMID: 31617074
Purpose: In the present study, we have systematically examined the clinical significance of Nectin-4 (encoded by the PVRL-4 gene), a marker for breast cancer stem cells (CSCs), in cancer metastasis...